ivw-1001

Small moleculeexperimental

Clinical trial activity

3 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Jun 25, 2024 (NCT06400459)

Timeline

2020s

  1. Jan 1, 2024

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2025

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07161011Phase 2Sep 8, 2025IVIEW Therapeutics Inc.
NCT07140380Phase 2Aug 20, 2025IVIEW Therapeutics Inc.
NCT06400459Phase 1/Phase 2 (Phase 2)Jun 25, 2024IVIEW Therapeutics Inc.
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
IVIEW Therapeutics Inc.For profit3312024
1 organizations
Page 1 / 1